Twist Bioscience (TWST) just rolled out research grade Plasmid DNA Preps tailored for pre clinical pharma and biotech work, a small but telling move that helps explain the recent uptick in the stock.
In early December 2025, Twist Bioscience launched research-grade Plasmid DNA Preps with animal origin-free and endotoxin-free options tailored to stringent preclinical study requirements. This move ...
From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.
Functionalized single-walled carbon nanotubes (SWCNTs) effectively delivered the amh/amhy plasmid into all-female mandarin ...
This report provides useful evidence that EABR mRNA is at least as effective as standard S mRNA vaccines for the SARS-CoV-2 booster vaccine. Although the methodology and the experimental approaches ...
Joshua Lederberg, Nobel laureate and president of Rockefeller University, is well known in biology circles. Not so his wife, ...
TriLink BioTechnologies senior scientist Dr Cody Palumbo discusses the blockers to manufacturing mRNA-based gene editing ...
TwistedSifter on MSN
Her Coworker Thought They Were Better Than Her, So She Decided To Get Revenge In The Best Possible Way
The post Her Coworker Thought They Were Better Than Her, So She Decided To Get Revenge In The Best Possible Way first on ...
Plasmid Purification Market to reach USD 6.6 Bn by 2035 at 12.3% CAGR, Driven by rising gene therapy demand, mRNA vaccines, ...
The bill, sponsored by Sen. Tom Corbin, would require providers to inform patients that the vaccine is “novel,” that it “may be contaminated by the presence of fragments of bacterial plasmid DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback